Pfizer has entered a five year collaborative agreement with the Global Medical Excellence Cluster (GMEC) in the UK that will conduct research and develop new medicines aimed at rare diseases. GMEC is comprised of six British universities: Cambridge University, Imperial College … Continue reading
June 9, 2014
by PharmaReviews
0 comments